Evidence map›Paper›PMID 28640945›Full record

ArticlePlant biotechnology journal2018

Production of human vitronectin in Nicotiana benthamiana using the INPACT hyperexpression platform.

Benjamin Dugdale, Maiko Kato, Pradeep Deo, Manuel Plan, Mark Harrison, Robyn Lloyd, Terry Walsh, Robert Harding, James Dale

Open access · goldAbstract read
In one paragraph

Article in Plant biotechnology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Benjamin DugdaleCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Maiko KatoCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Pradeep DeoCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Manuel PlanCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Mark HarrisonCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Robyn LloydCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Terry WalshCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Robert HardingCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
James DaleCentre for Tropical Crops and Biocommodities, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Queensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human vitronectin (hVN) is a glycoprotein that functions as a cell adhesion molecule and a regulator of coagulation in blood plasma and the extracellular matrix. In vitro, hVN is added to serum-free media in order to promote the adhesion of animal cells to tissue culture surfaces and the proliferation of undifferentiated stem cells. Here, we report the production of hVN in Nicotiana benthamiana using the inducible In Plant ACTivation (INPACT) hyperexpression platform. N. benthamiana plants were transformed with an INPACT expression cassette encoding hVN, and both the Tobacco yellow dwarf virus Rep/RepA activator and Tomato bushy stunt virus p19 gene under the transcriptional control of the ethanol-inducible AlcR:alcA gene switch. hVN expression was maximal 4-5 days postactivation of the INPACT platform with a dilute ethanol solution, and crude yields of the recombinant protein reached a maximum of 643 ± 78 mg/kg fresh weight. A three-stage purification protocol was developed using heparin and polyhistidine tag affinity binding and size exclusion filtration, resulting in a plant-made hVN product of >90% purity. Storage conditions for plant-made hVN were identified that maximized the capacity of the recombinant protein to promote cell adhesion. Critically, plant-made hVN was shown to be functionally equivalent to commercial, plasma-derived hVN at promoting one-half maximal attachment of murine fibroblast cells (BALB-C/3T3) in serum-free medium at <0.1 μg/cm

Indexed as

Gene Expression Regulation, PlantHumansNicotianaPlants, Genetically ModifiedVitronectinVitronectinbiopharminginducibleINPACTNicotiana benthamianatransgene expressionvitronectin

Identifiers

PMID28640945
PMCPMC5787849
OpenAlexW2713001338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.